| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Animal Health Service, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands
2 Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853
One hundred and fifty-nine cases of clinical Staphylococcus aureus mastitis were analyzed to detect factors associated with bacteriological cure after therapy. On 100 Dutch dairy farms, data were collected from four clinical trials with five intramammary treatment regimes designed to treat ß-lactamase-positive pathogens. Infected quarters were treated three times, with a 12-h interval between treatments. Treatment was extended for 2 d if results of the trial treatment were, according to the owner, not satisfactory. The overall bacteriological cure rate was 52%. The bacteriological cure rate of clinical ß-lactamase-negative S. aureus mastitis was significantly higher than that of clinical ß-lactamase-positive S. aureus mastitis. Bacteriological cure was also significantly higher if somatic cell count of the cow was low at the milk recording prior to the onset of the clinical mastitis. The bacteriological cure rate of clinical ß-lactamase-negative S. aureus mastitis was also significantly higher after an extended treatment compared with no extended treatment. The seriousness of the various clinical symptoms and the bacteriological cure rate of clinical S. aureus mastitis were not associated.
Key Words: clinical mastitis • antibiotic treatment • risk factors • Staphylococcus aureus
Submitted on December 28, 1998
Accepted on July 7, 1999
This article has been cited by other articles:
|
|
 |
|
  D. Petitclerc, K. Lauzon, A. Cochu, C. Ster, M. S. Diarra, and P. Lacasse Efficacy of a Lactoferrin-Penicillin Combination to Treat {beta}-Lactam-Resistant Staphylococcus aureus Mastitis J Dairy Sci, June 1, 2007; 90(6): 2778 - 2787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McDougall, K. E. Agnew, R. Cursons, X. X. Hou, and C. R. W. Compton Parenteral Treatment of Clinical Mastitis with Tylosin Base or Penethamate Hydriodide in Dairy Cattle J Dairy Sci, February 1, 2007; 90(2): 779 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sarikaya and R. M. Bruckmaier Importance of the sampled milk fraction for the prediction of total quarter somatic cell count. J Dairy Sci, November 1, 2006; 89(11): 4246 - 4250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Bilby, J. Block, B. C. do Amaral, O. Sa Filho, F. T. Silvestre, P. J. Hansen, C. R. Staples, and W. W. Thatcher Effects of dietary unsaturated Fatty acids on oocyte quality and follicular development in lactating dairy cows in summer. J Dairy Sci, October 1, 2006; 89(10): 3891 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Falagas, K. N. Fragoulis, and I. A. Bliziotis Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2536 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moroni, G. Pisoni, M. Antonini, R. Villa, P. Boettcher, and S. Carli Short communication: antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. J Dairy Sci, August 1, 2006; 89(8): 2973 - 2976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sarikaya, G. Schlamberger, H. H. D. Meyer, and R. M. Bruckmaier Leukocyte populations and mRNA expression of inflammatory factors in quarter milk fractions at different somatic cell score levels in dairy cows. J Dairy Sci, July 1, 2006; 89(7): 2479 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-A. Tenhagen, G. Koster, J. Wallmann, and W. Heuwieser Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J Dairy Sci, July 1, 2006; 89(7): 2542 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Barkema, Y. H. Schukken, and R. N. Zadoks Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci, June 1, 2006; 89(6): 1877 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. LeBlanc, K. D. Lissemore, D. F. Kelton, T. F. Duffield, and K. E. Leslie Major advances in disease prevention in dairy cattle. J Dairy Sci, April 1, 2006; 89(4): 1267 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Soback Reply to: "Letter to the Editor: Concerning an Article Comparing the Efficacy of Local and Systemic Treatment of Clinical Mastitis" J Dairy Sci, December 1, 2005; 88(12): 4135 - 4135. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Swinkels, H. Hogeveen, and R. N. Zadoks A Partial Budget Model to Estimate Economic Benefits of Lactational Treatment of Subclinical Staphylococcus aureus Mastitis J Dairy Sci, December 1, 2005; 88(12): 4273 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pyorala Letter to the Editor: Concerning an Article Comparing the Efficacy of Local and Systemic Treatment of Clinical Mastitis J Dairy Sci, May 1, 2005; 88(5): 1617 - 1617. [Full Text] [PDF]
|
|
|
|
|
|
H. A. Deluyker, S. N. Van Oye, and J. F. Boucher Factors Affecting Cure and Somatic Cell Count After Pirlimycin Treatment of Subclinical Mastitis in Lactating Cows J Dairy Sci, February 1, 2005; 88(2): 604 - 614. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
